Lv41
530 积分 2024-04-11 加入
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)
3天前
已完结
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
4个月前
已完结
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
4个月前
已完结
Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations
4个月前
已完结
Atrial Fibrillation: A Review of Treatments and Current Guidelines
5个月前
已完结
[Chinese guidelines on diagnosis and management of atrial fibrillation]
5个月前
已完结
Chinese Expert consensus on the diagnosis and treatment of adult dermatomyositis （2022）
6个月前
已完结
Reversal agents for current and forthcoming direct oral anticoagulants
7个月前
已完结
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis
7个月前
已完结
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
7个月前
已完结
皖公网安备34019202002308
